ATyr Pharma Stock Target Price and Analyst Consensus

LIFE Stock  USD 2.00  0.08  4.17%   
The current analyst and expert consensus on ATyr Pharma is Buy, with 0 strong buy opinions. The current projected ATyr Pharma target price consensus is 23.2 with 4 analyst opinions. The most common way ATyr Pharma analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview ATyr Pharma executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on ATyr Pharma. We encourage you to use your own analysis of ATyr Pharma to validate this buy or sell advice. ATyr Pharma buy-or-sell recommendation module provides average expert sentiment on the projected ATyr Pharma target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on ATyr Pharma to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For information on how to trade ATyr Stock refer to our How to Trade ATyr Stock guide.
Lowest Forecast
21.11
Highest Forecast
25.75
Target Price
23.2
The current year's Gross Profit is expected to grow to about (2.3 M). The current year's Pretax Profit Margin is expected to grow to -135.63. At present, ATyr Pharma's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Cash And Short Term Investments is expected to grow to about 156.6 M, whereas Total Current Liabilities is forecasted to decline to about 15.6 M.
  
It's important to approach ATyr Pharma's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize ATyr Pharma price targets

ATyr Pharma's stock target price is an estimate of its future price, usually made by analysts. Using ATyr Pharma's target price to determine if it is a suitable investment can be done through the following steps:
  • Look at ATyr Pharma's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if ATyr Pharma's stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional ATyr Pharma Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of ATyr Pharma is a key component of ATyr Pharma valuation and have some predictive power on the future returns of a ATyr Pharma.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ATyr Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.102.016.93
Details
Intrinsic
Valuation
LowRealHigh
1.807.2612.18
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.29-0.24-0.18
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as ATyr Pharma. Your research has to be compared to or analyzed against ATyr Pharma's peers to derive any actionable benefits. When done correctly, ATyr Pharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in ATyr Pharma.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Disruptive Technologies Idea
Disruptive Technologies
Invested few shares
Driverless Cars Idea
Driverless Cars
Invested a lot of shares
Macroaxis Picks Idea
Macroaxis Picks
Invested over 100 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 40 shares
ESG Investing Idea
ESG Investing
Invested few shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
When determining whether ATyr Pharma is a strong investment it is important to analyze ATyr Pharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ATyr Pharma's future performance. For an informed investment choice regarding ATyr Stock, refer to the following important reports:
Check out Macroaxis Advice on ATyr Pharma to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For information on how to trade ATyr Stock refer to our How to Trade ATyr Stock guide.
Note that the ATyr Pharma information on this page should be used as a complementary analysis to other ATyr Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Complementary Tools for ATyr Stock analysis

When running ATyr Pharma's price analysis, check to measure ATyr Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ATyr Pharma is operating at the current time. Most of ATyr Pharma's value examination focuses on studying past and present price action to predict the probability of ATyr Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ATyr Pharma's price. Additionally, you may evaluate how the addition of ATyr Pharma to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
The data published in ATyr Pharma's official financial statements usually reflect ATyr Pharma's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of ATyr Pharma. For example, before you start analyzing numbers published by ATyr accountants, it's critical to develop an understanding of what ATyr Pharma's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of ATyr Pharma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ATyr Pharma's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in ATyr Pharma's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of ATyr Pharma. Please utilize our Beneish M Score to check the likelihood of ATyr Pharma's management manipulating its earnings.